1-3 of 3
Guadalupe Rodriguez
Close
Sort by
Journal Articles

Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study

Emanuele Angelucci, MD, Junmin Li, Peter L Greenberg, MD, Wu Depei, MD, PhD, Ming Hou, MD, Efreen Montaño Figueroa, PhD, Guadalupe Rodriguez, Xunwei Dong, Jagannath Ghosh, Orna Bornstein, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 234.
https://doi.org/10.1182/blood-2018-99-111134
Published: 2018
Journal Articles

Differences In Treatment and Diagnostic Patterns In Private Vs Public Sectors For Deletion 5Q Myelodysplastic Syndromes (MDS) In Mexico: Results From A Physician Survey

Michelle Ann Soriano, PhD, Roberto Ovilla, MD, Maria Guadalupe Rodríguez-González, MD, Renée Arnold, PharmD, RPh, Dalia Mahmoud, MBA
Journal: Blood
Blood (2013) 122 (21): 5593.
https://doi.org/10.1182/blood.V122.21.5593.5593
Published: 2013
Journal Articles

Cytogenetics As a Prognostic Factor Of The Overall Survival (OS) Of Mexican Patients With Myelodysplastic Syndrome (MDS)

Maria Guadalupe Rodriguez-Gonzalez, MD, Yaneth Martinez-Ibarra, MD, Jorge Vela-Ojeda, MD, PhD, Kevin Nacho-Vargas, MD, Luis Meillon, MD, Yamile Fattel, MD, Julio Robledo, MD, MSc, Tonatiuh Romero-Salas, PhD, Moises Xolotl-Castillo, MD
Journal: Blood
Blood (2013) 122 (21): 5236.
https://doi.org/10.1182/blood.V122.21.5236.5236
Published: 2013